• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form F-6 POS filed by Puxin Limited

    1/31/22 6:29:42 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous
    Get the next $NEW alert in real time by email
    F-6 POS 1 22-06_f-6pos.htm
    As filed with the Securities and Exchange Commission on January 31, 2022
    Registration No. 333-225351

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C.  20549
    _________________________

    POST-EFFECTIVE AMENDMENT NO. 1 TO
    FORM F-6
    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOR
    DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS
    _________________________
    Puxin Limited
    (Exact name of issuer of deposited securities as specified in its charter)
    _________________________
    Not Applicable
    (Translation of issuer’s name into English)
    _________________________
    Cayman Islands
    (Jurisdiction of incorporation or organization of issuer)
    _________________________
    Deutsche Bank Trust Company Americas
    (Exact name of depositary as specified in its charter)
    1 Columbus Circle
    New York, New York 10019
    +1 (212) 250-9100
    (Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)
    _________________________
    Cogency Global Inc.
    122 East 42nd Street, 18th Floor
    New York, NY 10168
    +1 (212) 947-7200
    (Address, including zip code, and telephone number, including area code, of agent for service)
    _________________________
    Copies to:
    Christopher Doerksen
    Dorsey & Whitney LLP
    701 Fifth Avenue, Suite 6100
    Seattle, WA 98104
    +1 (206) 903-8800
     
     
    Jason Lin
    Dorsey & Whitney LLP
    Twin Towers (West), Suite 1503-1505
    B12 Jianguomenwai Avenue
    Chaoyang District, Beijing 100022
    People’s Republic of China
    +86 (10) 8513-5900
     
    Melissa Butler, Esq.
    White & Case LLP
    5 Old Broad Street
    London EC2N 1DW
    United Kingdom
    +(44) 20 7532-1502
    --------------------------------------------
    It is proposed that this filing become effective under Rule 466:
     ☒  immediately upon filing.
     
     ☐  on (Date) at (Time).
    If a separate registration statement has been filed to register the deposited shares, check the following box:
    ☒

    --------------------------------------------
    CALCULATION OF REGISTRATION FEE
    Title of each class
    of Securities to be registered
    Amount to be registered
    Proposed
    maximum aggregate price per unit (1)
    Proposed
    maximum aggregate offering price (2)
    Amount of registration fee(3)
    American Depositary Shares, each representing 20 ordinary shares of Puxin Limited
    N/A
    N/A
    N/A
    N/A

    1
    For the purpose of this table only the term “unit” is defined as one American Depositary Share.
    2
    Estimated solely for the purpose of calculating the registration fee.  Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of American Depositary Shares.
    3
    Previously paid.
    This registration statement may be executed in any number of counterparts, each of which shall be deemed an original, and all of such counterparts together shall constitute one and the same instrument.

    EXPLANATORY NOTE
    This Post-Effective Amendment No. 1 to the Registration Statement on Form F-6 (Registration No. 333-225351) is being filed solely to (i) effect a ratio change for each American Depositary Share so that the new ratio shall be one (1) American Depositary Share to twenty (20) ordinary shares of Puxin Limited and (ii) make corresponding changes reflecting the ratio change to the previously filed Deposit Agreement.
    PART I


    INFORMATION REQUIRED IN PROSPECTUS
    The prospectus consists of the proposed form of American Depositary Receipt (“Receipt”) included as Exhibits A and B to the form of Amendment No. 1 to the Deposit Agreement filed as Exhibit (a)(ii) to this Post-Effective Amendment to the Registration Statement on Form F-6 (File No.333-225351) previously filed by the Registrant, which is incorporated herein by reference.
    Item 1.
    DESCRIPTION OF SECURITIES TO BE REGISTERED

    Required Information
     
    Location in Form of Receipt Filed Herewith as Prospectus
     
    1.
    Name of depositary and address of its principal executive office
    Face of Receipt – introductory paragraph
    2.
    Title of Receipts and identity of deposited securities
    Face of Receipt – top center
    Terms of Deposit:
     
    (i)
    The amount of deposited securities represented by one American Depositary Share (“ADS”)
    Face of Receipt – upper right corner
     
    (ii)
    The procedure for voting the deposited securities
    Reverse of Receipt – Articles 14 and 15
     
    (iii)
    The procedure for collecting and distributing dividends
    Reverse of Receipt – Articles 13 and 14
     
    (iv)
    The procedures for transmitting notices, reports and proxy soliciting material
    Face of Receipt – Article 12;
    Reverse of Receipt – Articles 14 and 15
     
    (v)
    The sale or exercise of rights
    Reverse of Receipt – Articles 13 and 14
     
    (vi)
    The deposit or sale of securities resulting from dividends, splits or plans of reorganization
    Face of Receipt – Articles 3, 6 and 9;
    Reverse of Receipt – Articles 13 and 16
     
    (vii)
    Amendment, extension or termination of the deposit arrangements
    Reverse of Receipt – Articles 20 and 21 (no provision for extension)
     
    (viii)
    The rights of holders of Receipts to inspect the books of the depositary and the list of holders of Receipts
    Face of Receipt – Article 12
     
    (ix)
    Restrictions upon the right to transfer or withdraw the underlying securities
    Face of Receipt – Articles 2, 3, 4, 6, 8, 9 and 10;
    Reverse of Receipt – Article 22
     
    (x)
    Limitation on the depositary’s liability
    Face of Receipt – Articles 6 and 10;
    Reverse of Receipt – Articles 15, 16, 17 and 18
    3.
    Fees and charges that a holder of Receipts may have to pay, either directly or indirectly
    Face of Receipt – Article 9

    Item 2.
    AVAILABLE INFORMATION

    Puxin Limited (the “Company”) is subject to the periodic reporting requirements of the United States Securities Exchange Act of 1934, as amended, and, accordingly, files certain reports with, and furnishes certain reports to, the U.S. Securities and Exchange Commission (the “Commission”).  These reports can be retrieved from the Commission’s website (www.sec.gov) and can be inspected and copied at the public reference facilities maintained by the Commission at 100 F Street, N.E., Washington D.C. 20549.

    PART II


    INFORMATION NOT REQUIRED IN PROSPECTUS
    Item 3.
    EXHIBITS

     
    (a)(i)
    Form of Deposit Agreement, by and among the Company, Deutsche Bank Trust Company Americas, as depositary (the “Depositary”), and all holders and beneficial owners from time to time of ADSs issued thereunder (“Deposit Agreement”).  — Previously filed as Exhibit (a) to Form F-6 (File No. 333-225351) and incorporated herein by reference.
     
    (a)(ii)
    Amendment No. 1 to the Deposit Agreement— Filed herewith as Exhibit (a)(ii).
     
    (b)
    Any other agreement to which the Depositary is a party relating to the issuance of the ADSs registered hereunder or the custody of the deposited securities represented thereby. — Not applicable.
     
    (c)
    Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. — Not applicable.
     
    (d)
    Opinion of White & Case LLP, counsel to the Depositary, as to the legality of the securities to be registered. — Previously filed as Exhibit (d) to Form F-6 (File No. 333-225351).
     
    (e)
    Certification under Rule 466. — Filed herewith as Exhibit (e).
     
    (f)
    Powers of attorney for certain officers and directors of the Company. — Set forth on the signature pages hereto

    Item 4.
    UNDERTAKINGS

     
    (a)
    The Depositary hereby undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of the ADRs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities; and (2) made generally available to the holders of the underlying securities by the issuer.
     
    (b)
    If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request.  The Depositary undertakes to notify each registered holder of an ADR thirty (30) days before any change in the fee schedule.

    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post- Effective Amendment No.1 to the Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on January 31, 2022.
     
    Legal entity created by the form of Deposit Agreement for the issuance of American Depositary Receipts for ordinary shares, par value US$0.00005 per share of Puxin Limited.
       
     
    Deutsche Bank Trust Company Americas, as Depositary
       
       
     
    By:
    /s/ Michael Tompkins
     
       
    Name: Michael Tompkins
     
       
    Title: Director
     
           
           
     
    By:
    /s/ Kelvyn Correa
     
       
    Name: Kelvyn Correa
     
       
    Title: Director
     

    Pursuant to the requirements of the Securities Act of 1933, as amended, Puxin Limited certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post-Effective Amendment No.1 to Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in Beijing, the People’s Republic of China, on January 31, 2022.
     
    Puxin Limited
       
       
     
    By:
     /s/ Yunlong Sha
     
       
    Name: Yunlong Sha
     
       
    Title: Chief Executive Officer
     

    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Yunlong Sha and Peng Wang, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this registration statement and any and all related registration statements pursuant to Rule 462(b) of the Securities Act and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
    Under the requirements of the Securities Act, this Post-Effective Amendment No.1 to the Registration Statement on Form F-6 has been signed by the following persons on January 31, 2022, in the capacities indicated.
    Signature
     
    Title
     
    /s/ Yunlong Sha
    Chairman of the Board of Directors and Chief Executive Officer
    (principal executive officer)
    Name:  Yunlong Sha
    /s/ Ming Hu
    Director
    Name:  Ming Hu
    /s/ Yonghong Fan
    Director
    Name:  Yonghong Fan
    /s/ Neng Wang
    Director
    Name: Neng Wang
    /s/ Peng Wang
    Chief Financial Officer
    (principal financial officer and principal accounting officer)
    Name: Peng Wang




    SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES
    Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Puxin Limited, has signed this Post-Effective Amendment No.1 to the Registration Statement on Form F-6 in New York, New York, United States of America on January 31, 2022.
     
    Authorized U.S. Representative-Cogency Global Inc.
       
       
     
    By:
    /s/ Colleen De Vires
     
       
    Name:  Colleen De Vries
     
       
    Title:  Sr. Vice President on behalf of Cogency Global Inc.
     

    Index to Exhibits
    Exhibit
     
    Document
     
    (a)(ii)
    Amendment No. 1 to the Deposit Agreement
    (e)
    Rule 466 Certification

    Get the next $NEW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NEW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NEW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Puxin Limited Announces Changes to Board Composition

    BEIJING, April 28, 2022 /PRNewswire/ -- Puxin Limited (NYSE:NEW) ("Puxin" or the "Company"), a private educational services provider in China, today announced that the Company has appointed Mr. Liang Zeng as an independent director to the Company's board of directors (the "Board"), effective April 28, 2022. Mr. Liang Zeng will also serve as a member on the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board. Mr. Zeng is a well-known Internet entrepreneur and angel investor. He has extensive experience in strategic planning, business development and operation management in industries such as digital marketing, mobile Internet and artificial i

    4/28/22 5:00:00 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    Puxin Limited Announces Change of Auditor to MBP

    BEIJING, March 7, 2022 /PRNewswire/ -- Puxin Limited (NYSE:NEW) ("Puxin" or the "Company"), a private educational services provider in China, today announced that the Company appointed Marcum Bernstein & Pinchuk LLP ("MBP") as the Company's independent registered public accounting firm for its fiscal year ended December 31, 2021. At the same time, the Company and Deloitte Touche Tohmatsu Certified Public Accountants LLP ("Deloitte") have mutually agreed to terminate Deloitte's appointment as the Company's independent registered public accounting firm, effective immediately. The Company's decision to replace Deloitte with MBP was approved by the Audit Committee of the Company. Deloitte was pr

    3/7/22 6:00:00 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    Puxin Limited Announces Regain Compliance with NYSE Minimum Price Requirement

    BEIJING, Feb. 21, 2022 /PRNewswire/ -- Puxin Limited (NYSE:NEW) ("Puxin" or the "Company"), a private educational services provider in China, today announced that based on a notification letter it received on February 18, 2022 from the New York Stock Exchange ("NYSE"), the Company has regained compliance with the NYSE's continued listing standard for share prices. On August 18, 2021, the Company was notified by the New York Stock Exchange ("NYSE") of its noncompliance with the NYSE's continued listing standards because the average closing price of its American depositary shares had fallen below $1.00 over a period of 30 consecutive trading days. In order to regain compliance with the minimum

    2/21/22 6:03:00 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    $NEW
    SEC Filings

    View All

    SEC Form 25-NSE filed by Puxin Limited

    25-NSE - Puxin Ltd (0001726189) (Subject)

    5/25/22 3:17:41 PM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    SEC Form 6-K filed by Puxin Limited

    6-K - Puxin Ltd (0001726189) (Filer)

    5/10/22 7:34:44 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    SEC Form NT 20-F filed by Puxin Limited

    NT 20-F - Puxin Ltd (0001726189) (Filer)

    4/29/22 4:12:10 PM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    $NEW
    Financials

    Live finance-specific insights

    View All

    Puxin to Report Second Quarter 2021 Financial Results on December 29, 2021

    BEIJING, Dec. 22, 2021 /PRNewswire/ -- Puxin Limited (NYSE:NEW) ("Puxin" or the "Company"), a private educational services provider in China, today announced that it will report its financial results for the second quarter ended June 30, 2021, before U.S. markets open on December 29, 2021. About Puxin Limited Puxin Limited (NYSE:NEW) ("Puxin" or the "Company") is a private educational services provider in China. Puxin has a strong acquisition and integration expertise to effectively improve education quality and operational performance of acquired schools. Puxin offers quality educational services to students, and has developed online and mobile applications to enhance students' learning exp

    12/22/21 6:30:00 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    $NEW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Puxin Limited (Amendment)

    SC 13G/A - Puxin Ltd (0001726189) (Subject)

    7/11/22 4:12:38 PM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    SEC Form SC 13G filed by Puxin Limited

    SC 13G - Puxin Ltd (0001726189) (Subject)

    4/19/21 10:14:14 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous

    SEC Form SC 13G/A filed

    SC 13G/A - Puxin Ltd (0001726189) (Subject)

    2/11/21 6:16:58 AM ET
    $NEW
    Service to the Health Industry
    Miscellaneous